Improved results of a surgical resection for the recurrence of hepatocellular carcinoma after living donor liver transplantation

Annals of Surgical Oncology

Volumn 17, Issue 9, 2010, Pages 2283-2289

  Taketomi, Akinobu ^a   Fukuhara, Takasuke ^a   Morita, Kazutoyo ^a   Kayashima, Hiroto ^a   Ninomiya, Mizuki ^a   Yamashita, Yoichi ^a   Ikegami, Toru ^a   Uchiyama, Hideaki ^a   Yoshizumi, Tomoharu ^a   Soejima, Yuji ^a   Shirabe, Ken ^a   Maehara, Yoshihko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; GEMCITABINE;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; RECURRENCE RISK; TREATMENT OUTCOME;

ADULT; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77956339306     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-0999-y     Document Type: Article

References (25)

1. A Taketomi Y Soejima T Yoshizumi, et al. 2008 Liver transplantation for hepatocellular carcinoma J Hepatobiliary Pancreat Surg. 15 124 130 10.1007/s00534-007-1296-4 18392704
2. V Mazzaferro YS Chun RT Poon, et al. 2008 Liver transplantation for hepatocellular carcinoma Ann Surg Oncol. 15 1001 1007 10.1245/s10434-007-9559-5 18236119
3. V Mazzaferro JM Llovet R Miceli, et al. 2009 Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis Lancet Oncol. 10 35 43 10.1016/S1470-2045(08)70284-5 19058754
4. Furukawa H, Shimamura T, Suzuki T, et al. Liver transplantation for hepatocellular carcinoma: the Japanese experience. J Hepatobiliary Pancreat Surg. doi: 10.1007/s00534-009-0168-5 [Online September 18, 2009].
5. S Todo H Furukawa 2004 Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan Ann Surg. 240 451 459 10.1097/01.sla.0000137129.98894.42 15319716
6. FY Yao 2008 Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria Am J Transplant. 8 1982 1989 10.1111/j.1600-6143.2008.02351.x 1:STN:280:DC%2BD1cnjslKqtw%3D%3D 18727702
7. A Taketomi K Sanefuji Y Soejima, et al. 2009 Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation Transplantation. 87 531 537 10.1097/TP.0b013e3181943bee 19307789
8. M Fujiki Y Takada Y Ogura, et al. 2009 Significance of des-gamma-carboxy prothrombin in selection criteria for living donor liver transplantation for hepatocellular carcinoma Am J Transplant. 9 2362 2371 10.1111/j.1600-6143.2009. 02783.x 1:CAS:528:DC%2BD1MXhtlWlurrF 19656125
9. Y Sugawara S Tamura M Makuuchi 2007 Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series Dig Dis. 25 310 312 10.1159/000106910 17960065
10. WC Chapman MB Majella Doyle JE Stuart, et al. 2008 Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation Ann Surg. 248 617 625 18936575
11. G Millonig IW Graziadei MC Freund, et al. 2007 Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma Liver Transpl. 13 272 279 10.1002/lt.21033 17256758
12. Y Soejima A Taketomi T Yoshizumi, et al. 2006 Feasibility of left lobe living donor liver transplantation between adults: an 8-year, single-center experience of 107 cases Am J Transplant. 6 1004 1011 10.1111/j.1600-6143.2006. 01284.x 1:STN:280:DC%2BD283gsVKqsA%3D%3D 16611337
13. A Taketomi H Kayashima Y Soejima, et al. 2009 Donor risk in adult-to-adult living donor liver transplantation: impact of left lobe graft Transplantation. 87 445 450 10.1097/TP.0b013e3181943d46 19202452
14. JG O'Grady RJ Polson K Rolles, et al. 1988 Liver transplantation for malignant disease. Results in 93 consecutive patients Ann Surg 207 373 379 10.1097/00000658-198804000-00002 2451484
15. S Roayaie JD Schwartz MW Sung, et al. 2007 Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis Liver Transpl. 10 534 540 10.1002/lt.20128
16. B Perez Saborido SJ de los Galanes JC Meneu Diaz, et al. 2007 Tumor recurrence after liver transplantation for hepatocellular carcinoma: recurrence pathway and prognostic factors Transplant Proc. 39 2304 2307 10.1016/j.transproceed.2007.06.059 1:STN:280:DC%2BD2srmvV2ntw%3D%3D 17889172
17. Kornberg A, Kupper B, Tannapfel A, et al. Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: clinical patterns and outcome variables. Eur J Surg Oncol. doi: 10.1016/j.ejso.2009.10. 001 [Online October 24, 2009].
18. HJ Schlitt M Neipp A Weimann, et al. 1999 Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation J Clin Oncol. 17 324 331 1:STN:280:DyaK1MzosFCgsA%3D%3D 10458250
19. I Yokoyama B Carr H Saitsu, et al. 1991 Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation Cancer. 68 2095 2100 10.1002/1097-0142(19911115)68:10<2095::AID-CNCR2820681002>3.0.CO;2-Y 1:STN:280:DyaK38%2FgsFWmtQ%3D%3D 1655200
20. M Vivarelli A Cucchetti F Piscaglia, et al. 2005 Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression Liver Transpl. 11 497 503 10.1002/lt.20391 15838913
21. DS Bai Z Dai J Zhou, et al. 2009 Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma Hepatology. 49 460 470 10.1002/hep.22638 1:CAS:528:DC%2BD1MXivFWhtrg%3D 19053044
22. KM Olthoff MH Rosove CR Shackleton, et al. 1995 Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma Ann Surg. 221 734 741 10.1097/00000658-199506000-00012 1:STN:280: DyaK2MzhsVChsw%3D%3D 7794077
23. CB Hsieh SJ Chou ML Shih, et al. 2008 Preliminary experience with gemcitabine and cisplatin adjuvant chemotherapy after liver transplantation for hepatocellular carcinoma Eur J Surg Oncol. 34 906 910 18166289
24. M Bassanello A Vitale FA Ciarleglio, et al. 2003 Adjuvant chemotherapy for transplanted hepatocellular carcinoma patients: impact on survival or HCV recurrence timing Transplant Proc. 35 2991 2994 10.1016/j.transproceed.2003.10. 075 1:CAS:528:DC%2BD3sXpvF2qu7c%3D 14697958
25. Z Wang J Zhou J Fan, et al. 2009 Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma J Cancer Res Clin Oncol. 135 715 722 10.1007/s00432-008-0506-z 1:CAS:528:DC%2BD1MXjvVagtbw%3D 19002496